Last reviewed · How we verify
NCT03756948: VETLT
Viscoelastic Tests-Guided Therapy In Liver Transplantation
NA trial testing Usual Care in Liver Transplant; Complications in 237 participants. Completed in 1 January 2018.
30 October 2015
Quick facts
| Lead sponsor | Hospital Israelita Albert Einstein |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 237 |
| Start date | 1 January 2007 |
| Primary completion | 30 October 2015 |
| Estimated completion | 1 January 2018 |
Drugs / interventions tested
- Usual Care
- Thromboelastometry-Guided Therapy with Synthetic Factor Concentrates
Conditions studied
- Liver Transplant; Complications — all drugs for Liver Transplant; Complications →
- Bleeding — all drugs for Bleeding →
- Hemostatic Disorder — all drugs for Hemostatic Disorder →
Sponsor
Hospital Israelita Albert Einstein
Who can join
18 and older, any sex, with Liver Transplant; Complications or Bleeding. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
BACKGROUND: Perioperative bleeding and transfusion are important causes of morbidity and mortality in patients undergoing liver transplantation. The aim of this study is to assess whether viscoelastic tests-guided therapy with the use of synthetic factor concentrates impact transfusion rates of hemocomponents in adult patients undergoing liver transplantation. METHODS: This is an interventional before-after comparative study. Patients undergoing liver transplantation before the implementation of a protocol using thromboelastometry and synthetic factor concentrates were compared to patients after the implementation. Primary outcome was transfusion of any hemocomponents. Secondary outcomes included: transfusion of red blood cells (RBC), fresh frozen plasma (FFP), cryoprecipitate or platelets, clinical complications, length of stay and in-hospital mortality.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Association between viscoelastic tests-guided therapy with synthetic factor concentrates and allogenic blood transfusion in liver transplantation: a before-after study.
Zamper RPC, Amorim TC, Queiroz VNF, Lira JDO, et al · · 2018 · cited 20× · PMID 30579327 · DOI 10.1186/s12871-018-0664-8
Verify or expand the search:
- PubMed search for NCT03756948
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Usual Care
Trials testing the same drug.
- NCT07513805 — Implementation of Routine Walking Speed Measurements in Older Veterans · NA · not yet recruiting
- NCT07225062 — Improving HIV Prevention and Substance Use Post-Sexual Assault Services · NA · not yet recruiting
- NCT07202975 — RE-SCALE: Rehabilitation Engagement and Scaled Access With eXtended Reality and Artificial Intelligence · NA · not yet recruiting
- NCT05744869 — SBAT for Health Equity · NA · not yet recruiting
- NCT07380932 — Catheter Ablation for AF in Patients With Severe Mitral Regurgitation After Successful Transcatheter Mitral-Valve Repair · NA · not yet recruiting
Other recruiting trials for Liver Transplant; Complications
Currently open trials in the same condition.
- NCT06257407 — Perioperative Hemostasis Management in Liver Transplantation · recruiting
- NCT06533592 — The Effect of the Type of Conduit-duct Anastomosis Technique on the Postoperative Course in Patients Undergoing Liver Tr · NA · recruiting
- NCT06400771 — Safety of DNP007 in Healthy Subjects · Phase 1 · recruiting
- NCT06386198 — HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients · NA · recruiting
- NCT06236568 — Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation · NA · recruiting
Other Hospital Israelita Albert Einstein trials
Trials by the same sponsor.
- NCT07447674 — ED Post-Discharge Digital Follow-Up: A Communication Comparison · NA · not yet recruiting
- NCT07398222 — Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study · recruiting
- NCT07233837 — Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units · NA · recruiting
- NCT06726707 — COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis · Phase 2, PHASE3 · withdrawn
- NCT07112846 — Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03756948 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Israelita Albert Einstein
- Last refreshed: 28 November 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03756948.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing